Brief: CanSino's Prelim 2023 Net Loss 1.4 Bln Yuan
Feb 23 (Reuters) - CanSino Biologics Inc 688185.SS :
* SAYS PRELIM 2023 NET LOSS AT 1.4 BILLION YUAN ($194.50
million)
Source text
Further company coverage: 688185.SS
($1 = 7.1980 Chinese yuan renminbi)
(Reporting by Beijing newsroom)
((Ella.Cao@thomsonreuters.com;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025